Global cancer prevention: An important pathway to global health and development

Public Health

Volumn 125, Issue 12, 2011, Pages 821-831

  Beaglehole, R ^a   Bonita, R ^a   Magnusson, R ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cancer; Chronic disease; Global health; Non communicable disease; Prevention; Regulation

Indexed keywords

CANCER; CAUSE OF DEATH; DISEASE CONTROL; GLOBALIZATION; HEALTH POLICY; INTEGRATED APPROACH; LEGISLATION; PUBLIC HEALTH; REGULATORY FRAMEWORK; RISK FACTOR; SMOKING;

ALCOHOL CONSUMPTION; CANCER CONTROL; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CAUSE OF DEATH; CLIMATE CHANGE; DISABILITY; ENVIRONMENTAL FACTOR; HUMAN; LAW; LIFE EXPECTANCY; PROPHYLAXIS; REGULATORY MECHANISM; RESPONSIBILITY; REVIEW; RISK FACTOR; SMOKING; COST OF ILLNESS; HEALTH; NEOPLASM;

COST OF ILLNESS; HUMANS; NEOPLASMS; RISK FACTORS; WORLD HEALTH;

EID: 84856683346     PISSN: 00333506     EISSN: 14765616     Source Type: Journal    
DOI: 10.1016/j.puhe.2011.09.029     Document Type: Review

References (118)

1. World Health Organization Global status report on noncommunicable diseases 2011, World Health Organization, Geneva.
2. Abegunde D., Mathers C., Adam T., Ortegon M., Strong K. The burden and costs of chronic disease in low income and middle-income countries. Lancet 2007, 370:1929-1938.
3. Anderson G. Missing in action: international aid agencies in poor countries to fight chronic disease. Health Aff 2009, 28:202-205.
4. Nugent R., Feigl A. Where have all the donors gone? Scarce donor funding for non-communicable diseases 2010, Working Paper No. 228, Center for Global Development, Washington, DC.
5. Geneau R., Stuckler D., Stachenko S., McKee M., Ebrahim S., Basu S., et al. Raising the priority of preventing chronic diseases: a political process. Lancet 2010, 376:1689-1698.
6. Alleyne G., Stuckler D., Alwan A. The hope and the promise of the UN resolution on non-communicable diseases. Globaliz Health 2010, 6:15. Available at:, [accessed 13/05/2011]. http://www.globalizationandhealth.com/content/6/1/15.
7. Global burden of disease and risk factors 2006, Oxford University Press, New York, Washington, DC: World Bank. A.D. Lopez, C.D. Mathers, M. Ezzati, D.T. Jamison, C.J.L. Murry (Eds.).
8. International agency for research on cancer website. Available at: [accessed 16/09/2010]. http://www.iarc.fr/.
9. Institute for health metrics and evaluation website. Available at: [accessed 15/09/2011]. http://www.healthmetricsandevaluation.org/.
10. World Health Organization. Global burden of disease. Available at: [accessed 15/09/2011]. http://www.who.int/topics/global_burden_of_disease/en/.
11. Cancer incidence in five continents 2007, vol. IX. IARC Scientific Publication No. 160. Lyon: IARC. M.P. Curado, B. Edwards, H.R. Shin, H. Storm, J. Ferlay, M. Heanue, P. Boyle (Eds.).
12. International Agency for Research on Cancer. Globocan 2008 fact sheet. Available at: [accessed 15/09/2011]. http://globocan.iarc.fr/factsheets/populations/factsheet.asp?uno=900.
13. Jemal A., Bray F., Center M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:61-90.
14. Mathers C., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006, 3:e442.
15. Thun M.J., DeLancey J.O., Center M.M., Jemal A., Ward E.M. The global burden of cancer: priorities for prevention. Carcinogenesis 2010, 31:100-110.
16. Hawkes C. Uneven dietary development: linking the policies and processes of globalization with the nutrition transition, obesity and diet-related chronic diseases. Globaliz Health 2006, 2:4. Available at:, [accessed 15/09/2011]. http://www.globalizationandhealth.com/content/2/1/4.
17. Stuckler D. Population causes and consequences of leading chronic diseases: a comparative analysis of prevailing explanations. Milbank Q 2008, 86:276-326.
18. Magnusson R. Non-communicable diseases and global health governance: enhancing global processes to improve health development. Globaliz Health 2007, 3:2. Available at:, [accessed 15/09/2011]. http://www.globalizationandhealth.com/content/3/1/2.
19. World Health Organization Preventing chronic disease: a vital investment 2005, World Health Organization, Geneva.
20. Suhrcke M., Nugent R.A., Stuckler D., Rocco L. Chronic disease: an economic perspective 2006, Oxford Health Alliance, London.
21. Beaglehole R., Bonita R., Alleyne G., Horton R., Li L., Lincoln P., et al. UN high-level meeting on non-communicable diseases: addressing four questions. Lancet 2011, 378:449-455.
22. World Health Organization World Health Report 2010: health systems financing: the path to universal coverage 2010, World Health Organization, Geneva, p. 5.
23. Brawley O. Avoidable cancer deaths globally. CA Cancer J Clin 2011, 61:67-68.
24. Danaei G., Vander Hoorn S., Lopez A., Murray C.J.L., Ezzati M. Comparative Risk Assessment Collaborating Group. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 2005, 366:1784-1793.
25. Jha P. Avoidable global cancer deaths and total deaths from smoking. Nat Rev Cancer 2009, 9:655-664.
26. World Health Organization Global health risks: mortality and burden of disease attributable to selected major risks 2009, World Health Organization, Geneva.
27. Terry P., Thun M., Rohan T. Does tobacco smoke cause breast cancer?. Women's Health 2011, 7:405-408.
28. World Health Organization. WHO framework convention on tobacco control. WHA56.1 (entered into force 27 February 2005).
29. Frieden T., Bloomberg M. How to prevent 100 million deaths from tobacco. Lancet 2007, 369:1758-1761.
30. Asaria P., Chisholm D., Mathers C., Ezzati M., Beaglehole R. Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet 2007, 370:2044-2053.
31. World Health Organization WHO report on the global tobacco epidemic 2011, World Health Organization, Geneva.
32. Jha P., Chaloupka F.J. The economics of tobacco control. BMJ 2000, 321:358-361.
33. World Health Organization Guidelines for implementation of Article 5.3 of the WHO Framework Convention on Tobacco Control - on the protection of public health policies with respect to tobacco control from commercial and other vested interests of the tobacco industry 2008, Decision FCTC/COP3(7), World Health Organisation, Geneva.
34. World Health Organization Tobacco industry interference with tobacco control. WHO tobacco control papers. San Francisco 2009, Center for Tobacco Control Research and Education, UC San Francisco.
35. Wakefield M., Terry-McElrath Y., Emery S., Saffer H., Chaloupka F., Szczypka G., et al. Effect of televised, tobacco company-funded smoking prevention advertising on youth smoking-related beliefs, intentions, and behavior. Am J Public Health 2006, 96:2154-2160.
36. Farrelly M., Healton C., Davis K., Messeri P., Hersey J., Haviland M. Getting to the truth: evaluating national tobacco countermarketing campaigns. Am J Public Health 2002, 92:901-907.
37. Landman A., Ling P., Glantz S. Tobacco industry youth smoking prevention programs: protecting the industry and hurting tobacco control. Am J Public Health 2002, 92:917-930.
38. Food and Drug Administration (FDA). Final rule restricting the sale, distribution and use of cigarettes and smokeless tobacco, codified at 21 CFR, part 1140. Available at: [accessed 15/09/2011]. http://www.fda.gov/TobaccoProducts/ProtectingKidsfromTobacco/RegsRestrictingSale/default.htm.
39. United States v Philip Morris Inc., Civil Action No. 99-2496 (GK), U.S. District Court for the District of Columbia, Amended Final Opinion of Judge Gladys Kessler, 8 September 2006, at §1510, §§1597-1602, and generally §§1403-1492, §§1508-1704. Available at: [accessed 15/09/2011]. http://www.usdoj.gov/civil/cases/tobacco2/index.htm.
40. Malone R. The tobacco industry. The bottom line or public health: tactics corporations use to influence health and health policy, and what we can do to counter them 2010, 155-191. Oxford University Press, New York. W. Wiist (Ed.).
41. Beaglehole R., Bonita R., Horton R., Adams C., Alleyne G., Asaria P. Lancet NCD Action Group and the NCD Alliance. Priority actions for the noncommunicable disease crisis. Lancet 2011, 377:1438-1447.
42. Schroeder S., Warner K. Don't forget tobacco. N Engl J Med 2010, 363:201-204.
43. Garrett B., Dube S., Trosclair A., Caraballo R., Pechacek T. Cigarette smoking - United States, 1965-2008. MMWR 2011, 60:109-113.
44. Robinson S., Harris H. Smoking and drinking among adults, 2009: a report on the 2009 General Lifestyle Survey 2011, Office for National Statistics, Available at:, [accessed 15/09/2011]. http://www.ons.gov.uk.
45. Smokefree Coalition - te ohu auahi kore. Tobacco free New Zealand 2020 - achieving the vision 2009, Wellington: The Smokefree Coalition. Available at:, [accessed 15/09/2011]. mailto:http://www.sfc.org.nz/.
46. Rehm J., Mathers C., Popova S., Thavorncharoensap M., Teerawattananon Y., Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 2009, 373:2223-2233.
47. World Bank Dying too young: addressing premature mortality and ill-health due to non-communicable diseases and injuries in the Russian Federation 2005, World Bank, Washington, DC.
48. Zaridze D., Brennan P., Boreham J., Boroda A., Karpov R., Lazarev A., et al. Alcohol and cause-specific mortality in Russia: a retrospective case-control study of 48 557 adult deaths. Lancet 2009, 373:2201-2214.
49. World Health Organization Global status report on alcohol and health 2011, World Health Organization, Geneva.
50. Boffetta P., Hashibe M., La Vecchia C., Zatonski W., Rehm J. The burden of cancer attributable to alcohol drinking. Int J Cancer 2006, 119:884-887.
51. Schütze M., Boeing H., Pischon T., Rehm J., Kehoe T., Gmel G., et al. Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study. BMJ 2011, 342:d1584.
52. Room R., Babor T., Rehm J. Alcohol and public health. Lancet 2005, 365:519-530.
53. Babor T., Caetano R., Casswell S., Edwards G., Giesbrecht N., Graham K., et al. Alcohol: no ordinary commodity 2010, Oxford University Press and Pan American Health Organization, New York. 2nd ed.
54. Anderson P., Chisholm D., Fuhr D. Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol. Lancet 2009, 373:2234-2246.
55. World Health Organization. Global strategy to reduce the harmful use of alcohol. WHA63/13 - Annex 2 (endorsed World Health Assembly May 2010). Available at: [accessed 16/09/2011]. http://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_13-en.pdf.
56. Leyshon M. New media, new problem? Alcohol, young people and the internet 2011, London: Alcohol Concern, Available at:, [accessed 17/09/2011]. http://www.alcoholconcern.org.uk/publications/policy-reports/new-media-new-problem.
57. Bond L., Daube M., Chikritzhs T. Selling addictions: similarities in approaches between big tobacco and big booze. Australas Med J 2010, 3:325-332.
58. New Zealand Law Commission Alcohol in our lives: curbing the harm. New Zealand law Commission report 114 2010, Wellington, New Zealand: Law Commission. Available at:, [accessed 16/09/2011]. http://www.lawcom.govt.nz/project/review-regulatory-framework-sale-and-supply-liquor.
59. No Increase to Tax on Alcohol. Radio New Zealand news 27 April 2010. Available at: [accessed 16/09/2011]. http://www.radionz.co.nz/news/national/31357/no-increase-to-tax-on-alcohol.
60. Room R., Schmidt L., Rehm J., Mäkelä P. International regulation of alcohol. BMJ 2008, 337:a2364.
61. Mitchell A, Voon T. Implications of the World Trade Organization in combating non-communicable diseases. University of Melbourne Legal Studies Research Paper No. 485; 2010; Available at: [accessed 16/09/2011]. http://ssrn.com/abstract=1626733.
62. World Cancer Research Fund/American Institute for Cancer Research Food, nutrition, physical activity, and the prevention of cancer: a global perspective 2007, American Institute for Cancer Research, Washington, DC, Available at:, [accessed 16/09/2011]. http://www.dietandcancerreport.org/.
63. Willett W. Fruits, vegetables, and cancer prevention: turmoil in the produce section. J Natl Cancer Inst 2010, 102:510-511.
64. Boffetta P., Couto E., Wichmann J., Ferrari P., Trichopoulos D., Bueno-de-Mesquita H., et al. Fruit and vegetable intake and overall cancer risk in the European Prospective Investigation into cancer and nutrition (EPIC). J Natl Cancer Inst 2010, 102:529-537.
65. Finucane M., Stevens G., Cowan M., Danaei G., Lin J., Paciorek C., et al. National, regional and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011, 377:557-567.
66. Stuckler D. Population causes and consequences of leading chronic diseases: a comparative analysis of prevailing explanations. Milbank Q 2010, 86:273-326.
67. Hawkes C., Chopra M., Friel S. Globalization, trade and the nutrition transition. Globalization and health: pathways, evidence and policy 2009, 235-262. Routledge, New York. T. Labonté, T. Schrecker, C. Packer, V. Runnels (Eds.).
68. Magnusson R. What's law got to do with it? Part 2: legal strategies for healthier nutrition and obesity prevention. Aust NZ Health Policy 2008, 5:11. Available at:, [accessed 16/09/2011]. http://www.anzhealthpolicy.com/content/5/1/11.
69. World Health Organization Global strategy on diet, physical activity and health 2004, Geneva: World Health Organisation. WHA57.17.
70. Brownell K., Warner K. The perils of ignoring history: big tobacco played dirty and millions died. How similar is big food?. Milbank Q 2009, 87:259-294.
71. Sharma L., Teret S., Brownell K. The food industry and self-regulation: standards to promote success and to avoid public health failures. Am J Public Health 2010, 100:240-246.
72. Magnusson R. Obesity prevention and personal responsibility: the case of front-of-pack food labeling in Australia. BMC Public Health 2010, 10:662. Available at:, [accessed 16/09/2011]. http://www.biomedcentral.com/1471-2458/10/662.
73. Kraak V., Kumanyika S., Story M. The commercial marketing of healthy lifestyles to address the global child and adolescent obesity pandemic: prospects, pitfalls and priorities. Public Health Nutr 2009, 12:2027-2036.
74. Thow A., Jan S., Leeder S., Swinburn B. The effect of fiscal policy on diet, obesity and chronic disease: a systematic review. Bull World Health Organ 2010, 88:609-614.
75. Andreyeva T., Long M., Brownell K. The impact of food prices on consumption: a systematic review of research on the price elasticity of demand for food. Am J Public Health 2010, 100:216-222.
76. Duffey K., Gordon-Larsen P., Shikany J., Guilkey D., Jacobs D., Popkin B. Food price and diet and health outcomes: 20 years of the CARDIA study. Arch Intern Med 2010, 170:420-426.
77. Brownell K., Farley T., Willett W., Popkin B., Chaloupka F., Thompson J., et al. The public health and economic benefits of taxing sugar-sweetened beverages. N Engl J Med 2009, 361:1599-1605.
78. World Health Organization. Set of recommendations on the marketing of foods and non-alcoholic beverages to children. WHA63.14. Available at: [accessed 16/09/2011]. http://www.who.int/dietphysicalactivity/marketing-food-to-children/en/index.html.
79. Harris J., Pomeranz J., Lobstein T., Brownell K. A crisis in the marketplace: how food marketing contributes to childhood obesity and what can be done. Ann Rev Public Health 2009, 30:211-225.
80. World Health Organization Global strategy for infant and young child feeding 2002, WHA55.25, Geneva: World Health Organisation. Available at:, [accessed 16/09/2011]. http://www.who.int/nutrition/publications/infantfeeding/en/index.html.
81. Commonwealth of Australia Labelling logic: review of food labelling law and policy 2011, Canberra: Commonwealth of Australia. Available at:, [accessed 16/09/2011]. http://www.foodlabellingreview.gov.au/internet/foodlabelling/publishing.nsf/content/labelling-logic.
82. World Health Organization Hepatitis B vaccines: WHO position paper. Wkly Epidemiol Rec 2009, 84:405-420.
83. World Health Organization. Initiative for vaccine research. Hepatitis C; Available at: [accessed 16/09/2011]. http://www.who.int/vaccine_research/diseases/viral_cancers/en/index2.html.
84. Flamm S. Chronic hepatitis C virus infection. JAMA 2003, 289:2413-2417.
85. Gable L., Gamharter K., Gostin L., Hodge J., van Puymbroeck R. Legal aspects of HIV/AIDS: a guide for policy and law reform. Section 4 2007, World Bank, Washington, DC, Available at:, [accessed 16/09/2011]. http://elibrary.worldbank.org/content/book/9780821371053.
86. World Health Organization Human papillomavirus vaccines: WHO position paper. Wkly Epidemiol Rec 2009, 84:118-132.
87. Cuschieri K. Should boys receive the human papillomavirus vaccine? No. BMJ 2009, 339:b4921.
88. Naucler P., Ryd W., Törnberg S., Strand A., Wadell G., Elfgren K. Human papillomavirus and papanicolaou tests to screen for cervical cancer. N Engl J Med 2007, 357:1589-1597.
89. Waldron H. A brief history of scrotal cancer. Br J Indust Med 1983, 40:390-401.
90. nd revised version.
91. United National Scientific Committee on the Effects of Atomic Radiation. Health effects due to radiation from the Chernobyl accident (Annex D) of UNSCEAR 2008 Report to the General Assembly entitled 'Sources and effects of ionising radiation'. p. 186. Available at: [accessed 16/09/2011]. http://www.unscear.org/unscear/en/publications.html.
92. International Atomic Energy Agency. Fukushima nuclear accident update log. Available at: [accessed 16/09/2011]. http://www.iaea.org/newscenter/news/tsunamiupdate01.html.
93. The INTERPHONE study group Brain tumour risk in relation to mobile telephone use: results of the INTERPHONE international case-control study. Int J Epidemiol 2010, 39:675-694.
94. Saracci R., Samet J. Commentary: call me on my mobile phone.or better not? A look at the INTERPHONE study results. Int J Epidemiol 2010, 39:695-698.
95. Baan R., Grosse Y., Lauby-Secretan B., El-Ghissassi F., Bouvard V., Benbrahim-Tallaa L., et al. Carcinogenicity of radiofrequency electromagnetic fields. Lancet Oncol 2011, 12:624-626.
96. COSMOS website. Available at: [accessed 16/09/2011]. http://www.ukcosmos.org/index.html.
97. The President's Cancer Panel 2008-2009 annual report: president's cancer panel. reducing environmental cancer risk: what we can do now 2010, Washington D.C.: U.S. Department of Health and Human Services.
98. Vogel S., Roberts J. Why the Toxic Substances Control Act needs an overhaul, and how to strengthen oversight of chemicals in the interim. Health Aff 2011, 30:898-905.
99. Fisher D., James W. Indoor tanning - science, behaviour, and policy. N Engl J Med 2010, 363:901-903.
100. World Health Organization. Sunbeds, tanning and UV exposure. Factsheet No. 287. Available at: [accessed 16/09/2011]. http://www.who.int/mediacentre/factsheets/fs287/en/.
101. Gies P., Javorniczky J., Henderson S., McLennan A., Roy C., Lock J., et al. UVR emissions from solaria in Australia and implications for the regulation process. Photochem Photobiol 2011, 87:184-190.
102. Thomson C., Woolnough S., Wickenden M., Hiom S., Twelves C. Sunbed use in children aged 11-17 in England: face to face quota sampling surveys in the national prevalence study and six cities study. BMJ 2010, 340:c877. Available at:, [accessed 16/09/2011]. http://www.bmj.com/content/340/bmj.c877.full.
103. Mosher C., Danoff-Burg S. Addiction to indoor tanning: relation to anxiety, depression, and substance use. Arch Determatol 2010, 146:412-417.
104. Patient Protection and Affordable Care Act P.L. 111-148, inserting chapter 49 into sub-title D of the Internal Revenue Code of 1986. Available at: [accessed 16/09/2011]. http://www.gpo.gov/fdsys/pkg/PLAW-111publ148/content-detail.html.
105. Dellavalle R., Parker E., Cersonsky N., Hester E., Hemme B., Burkhardt D., et al. Youth access laws: in the dark at the tanning parlor?. Arch Dermatol 2003, 139:443-448.
106. World Economic Forum Global risks 2011, Available at:, [accessed 16/09/2011]. http://riskreport.weforum.org/, 6th ed.
107. Frumkin H., Hess J., Luber G., Malilay J., McGeehin M. Climate change: the public health response. Am J Public Health 2008, 98:435-445.
108. Strong K., Mathers C., Leeder S., Beaglehole R. Preventing chronic diseases: how many lives could we save?. Lancet 2007, 366:1578-1582.
109. Essen K., Leeder S. The Millennium development goals and tobacco control 2004, World Health Organization, Geneva.
110. Engelgau M., El-Saharty S., Kudesia P., Rajan V., Rosenhouse S., Okamoto K. Capitalizing on the demographic transition: tackling noncommunicable diseases in South Asia 2011, World Bank, Washington, DC.
111. Stuckler D., Basu S., McKee M. Drivers of inequality in millennium development goal progress: a statistical analysis. PLoS Med 2010, 7:e1000241.
112. Samb B., Desai N., Nishtar S., Mendis S., Bekedam H., Wright A. Prevention and management of chronic disease: a litmus test for health-systems strengthening in low-income and middle-income countries. Lancet 2010, 376:1785-1797.
113. World Health Organization 2008-2013 action plan for the global strategy for the prevention and control of noncommunicable diseases 2008, World Health Organization, Geneva, Available at:, [accessed 16/09/2011]. http://www.who.int/nmh/publications/9789241597418/en/index.html.
114. Haines A., McMichael A., Smith K., Roberts I., Woodcock J., Markandya A., Armstrong B., et al. Public health benefits of strategies to reduce greenhouse-gas emissions: overview and implications for policy makers. Lancet 2009, 374:2104-2114.
115. Younger M., Morrow-Almeida H., Vindigni S., Dannenberg A. The built environment, climate change, and health: opportunities and co-benefits. Am J Prev Med 2008, 35:517-526.
116. NCD Alliance website. Available at: [accessed 16/09/2011]. http://www.ncdalliance.org/.
117. Magnusson R., Patterson D. Role of law in global response to non-communicable diseases. Lancet 2011, 378:859-860.
118. World Bank Towards a healthy and harmonious life in China: stemming the rising tide of non-communicable diseases 2011, World Bank, Washington, DC.